BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38835389)

  • 1. Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter?
    Yue H; Li X; You J; Feng P; Du Y; Wang R; Wu H; Cheng J; Ding K; Jing B
    Front Oncol; 2024; 14():1365897. PubMed ID: 38835389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation hematologic toxicity prediction for locally advanced rectal cancer using dosimetric and radiomics features.
    Yue H; Geng J; Gong L; Li Y; Windsor G; Liu J; Pu Y; Du Y; Wang R; Wu H; Jiao Z; Bai H; Jing B
    Med Phys; 2023 Aug; 50(8):4993-5001. PubMed ID: 36780152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiomics approach for predicting acute hematologic toxicity in patients with cervical or endometrial cancer undergoing external-beam radiotherapy.
    Le Z; Wu D; Chen X; Wang L; Xu Y; Zhao G; Zhang C; Chen Y; Hu Y; Yao S; Chen T; Ren J; Yang G; Liu Y
    Radiother Oncol; 2023 May; 182():109489. PubMed ID: 36706957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Factors and Radiomics Features Within Different Regions of Interest in Planning CT Images for Improving the Prediction of Radiation Pneumonitis.
    Jiang W; Song Y; Sun Z; Qiu J; Shi L
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1161-1170. PubMed ID: 33548340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-field radiotherapy for locally advanced cervical cancer.
    Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of radiation-induced acute skin toxicity in breast cancer patients using data encapsulation screening and dose-gradient-based multi-region radiomics technique: A multicenter study.
    Feng H; Wang H; Xu L; Ren Y; Ni Q; Yang Z; Ma S; Deng Q; Chen X; Xia B; Kuang Y; Li X
    Front Oncol; 2022; 12():1017435. PubMed ID: 36439515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the need for a replan in oropharyngeal cancer: A radiomic, clinical, and dosimetric model.
    Chinnery TA; Lang P; Nichols AC; Mattonen SA
    Med Phys; 2024 May; 51(5):3510-3520. PubMed ID: 38100260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bone marrow sparing radiotherapy on acute hematologic toxicity for patients with locoregionally advanced cervical cancer: a prospective phase II randomized controlled study.
    Li W; Ma L; Li F; Li K; Zhang Y; Ren H; Bao X; Guo Y; Guo Y; Wang M; Li D; Duan Y; Ma X; Wang Z; Wang Y; Yin R
    Radiat Oncol; 2024 Apr; 19(1):46. PubMed ID: 38594678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hematological toxicity during post-operative bowel sparing image-guided intensity modulated radiation with concurrent cisplatin.
    Lewis S; Chopra S; Naga P; Pant S; Dandpani E; Bharadwaj N; Mahantshetty U; Engineer R; Swamidas J; Ghosh J; Gupta S; Shrivastava S
    Br J Radiol; 2018 Dec; 91(1092):20180005. PubMed ID: 30179056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy.
    Meng X; Wang N; Yu M; Kong D; Zhang Z; Chang X; Guo Y; Li Y
    Front Public Health; 2022; 10():993443. PubMed ID: 36159246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
    Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
    Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
    Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absolute volume of PET-defined, active bone marrow spared predicts for high grade hematologic toxicity in cervical cancer patients undergoing chemoradiation.
    Zhou YM; Freese C; Meier T; Go D; Khullar K; Sudhoff M; Lamba M; Kharofa J
    Clin Transl Oncol; 2018 Jun; 20(6):713-718. PubMed ID: 29076030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
    Li M; Hu M; Wang Y; Yang X
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():1-6. PubMed ID: 31082737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc therapy.
    Xiang X; Ding Z; Zeng Q; Feng L; Qiu C; Chen D; Lu J; Li N
    Radiat Oncol; 2022 Mar; 17(1):48. PubMed ID: 35248087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy.
    Nie T; Chen Z; Cai J; Ai S; Xue X; Yuan M; Li C; Shi L; Liu Y; Verma V; Bi J; Han G; Yuan Z
    Radiother Oncol; 2024 Jan; 190():110047. PubMed ID: 38070685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosiomics and radiomics improve the prediction of post-radiotherapy neutrophil-lymphocyte ratio in locally advanced non-small cell lung cancer.
    Hou R; Xia W; Zhang C; Shao Y; Zhu X; Feng W; Zhang Q; Yu W; Fu X; Zhao J
    Med Phys; 2024 Jan; 51(1):650-661. PubMed ID: 37963229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review.
    Corbeau A; Kuipers SC; de Boer SM; Horeweg N; Hoogeman MS; Godart J; Nout RA
    Radiother Oncol; 2021 Nov; 164():128-137. PubMed ID: 34560187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics-based infarct features on CT predict hemorrhagic transformation in patients with acute ischemic stroke.
    Xie G; Li T; Ren Y; Wang D; Tang W; Li J; Li K
    Front Neurosci; 2022; 16():1002717. PubMed ID: 36213752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.